Keeney, Edna
Memtsa, Maria
Goodhart, Venetia
Jurkovic, Davor
Ambler, Gareth
Khan, Nazim
Round, Jeff
Article History
Received: 28 January 2021
Accepted: 18 February 2022
First Online: 9 March 2022
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. The study received a favourable ethics opinion from the North West Research Ethics Committee (reference 16/NW/0587) [see the relevant named documents for the full study approved protocol, patient and staff information leaflets and consent forms, data collection forms, unit data collection forms and unit protocol forms, URL: ExternalRef removed. Informed consent to participate in the study was obtained from all participants.
: Not applicable.
: EK reports personal fees from Novartis Pharmaceuticals UK Ltd. (London, UK), Roche Holding AG, and from Pfizer Inc. (Pfizer Inc., New York, NY, USA), outside the submitted work. JR is currently employed by the Institute of Health Economics. The Institute of Health Economics receives funding from, and collaborates with, government, academic, not-for-profit and private-sector organisations. The Institute of Health Economics does not currently receive funds for research related to the submitted work. MM, VG, DJ, GA and NK have no conflicts of interest to report.